| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure–Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)
|
Suzuki, Takeshi
|
|
|
19 |
1 |
p. 13-21.e3
|
artikel
|
| 2 |
Colorectal Large-Cell Neuroendocrine Carcinoma: Case Report and Literature Review for Potential Novel Therapeutic Options
|
Chen, Xiaoyi
|
|
|
19 |
1 |
p. 61-64
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
19 |
1 |
p. A1
|
artikel
|
| 4 |
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter Study
|
Auvray, Marie
|
|
|
19 |
1 |
p. 39-47.e5
|
artikel
|
| 5 |
Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence
|
Snyder, Rebecca A.
|
|
|
19 |
1 |
p. 1-4
|
artikel
|
| 6 |
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
|
Brunsell, Tuva Høst
|
|
|
19 |
1 |
p. e26-e47
|
artikel
|
| 7 |
Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer
|
Cavallaro, Paul
|
|
|
19 |
1 |
p. e8-e17
|
artikel
|
| 8 |
Oxaliplatin-Induced Evans Syndrome: A Possible Dual Mechanism
|
Rousseau, Celia
|
|
|
19 |
1 |
p. 57-60
|
artikel
|
| 9 |
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
|
Advani, Shailesh M.
|
|
|
19 |
1 |
p. 48-56.e2
|
artikel
|
| 10 |
Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
|
Le, Dung T.
|
|
|
19 |
1 |
p. 32-38.e3
|
artikel
|
| 11 |
S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial
|
Sunami, Eiji
|
|
|
19 |
1 |
p. 22-31.e6
|
artikel
|
| 12 |
Table of Contents
|
|
|
|
19 |
1 |
p. A3-A5
|
artikel
|
| 13 |
The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
|
Wieczorska, Karina
|
|
|
19 |
1 |
p. 5-12
|
artikel
|
| 14 |
Type and Consequences of Short-Term Complications in Colon Cancer Surgery, Focusing on the Oldest Old
|
Baré, Marisa
|
|
|
19 |
1 |
p. e18-e25
|
artikel
|
| 15 |
What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative
|
Lee, Rachel M.
|
|
|
19 |
1 |
p. e1-e7
|
artikel
|
Tijdschrift beschrijving